Target intelligence / Profile preview

Bacterial lysis of Staphylococcus aureus

Molecular classification
Other
01

Overview

Bacterial lysis of Staphylococcus aureus refers to the destruction of the cellular integrity of the Gram-positive pathogen S. aureus, leading to cell death and the release of intracellular contents (StatPearls, 2023). This process is primarily mediated by the degradation of the peptidoglycan layer in the bacterial cell wall, which provides the structural strength necessary to withstand high internal osmotic pressure (Nature Reviews Microbiology, 2015). Therapeutic agents achieve this through various mechanisms: beta-lactam antibiotics inhibit the penicillin-binding proteins involved in cell wall synthesis, while glycopeptides bind to peptidoglycan precursors to prevent cross-linking (Merck Manual, 2023). More recently, phage-derived endolysins like Exebacase have been developed to directly digest the cell wall, causing rapid lysis even in non-dividing cells (Frontiers in Microbiology, 2018). While lysis is essential for clearing infections, the rapid release of pro-inflammatory components such as lipoteichoic acid and peptidoglycan fragments can exacerbate host tissue damage and systemic inflammation (StatPearls, 2023).

Other names
BacteriolysisStaphylococcal lysisCell wall disruptionBacterial cell death
02

Mechanism of action

Inhibition of peptidoglycan cross-linking, binding to cell wall precursors, or direct enzymatic hydrolysis of the peptidoglycan backbone, leading to osmotic rupture (Merck Manual, 2023; Frontiers in Microbiology, 2018).

03

Biological functions

Cell deathOther
04

Disease associations

InfectionInflammation
05

Safety considerations

Release of inflammatory toxins (e.g., alpha-hemolysin)Jarisch-Herxheimer-like reactionsDevelopment of antimicrobial resistance (e.g., MRSA)Disruption of host commensal microbiota
06

Interacting drugs

Penicillin G

5 more in the full profile.

07

Biomarkers

ProcalcitoninC-reactive proteinBlood culture clearanceQuantitative PCR for S. aureus DNA

Beyond the preview

Go deeper on Bacterial lysis of Staphylococcus aureus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial lysis of Staphylococcus aureus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call